A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

• Published in: Journal of medical genetics 2003-10, Vol.40 (10), p.787-792
• Main Authors: Giusti, R M, Rutter, J L, Duray, P H, Freedman, L S, Konichezky, M, Fisher-Fischbein, J, Greene, M H, Maslansky, B, Fischbein, A, Gruber, S B, Rennert, G, Ronchetti, R D, Hewitt, S M, Struewing, J P, Iscovich, J
• Format: Article
• Language: English
• Subjects: Age; Analysis; Ashkenazi Jews; Ashkenazim; Biological and medical sciences; Biopsy; BRCA; Cancer patients; Care and treatment; Colorectal cancer; Demographic aspects; Epidemiology; Europe, Eastern - ethnology; Founder Effect; Gene Frequency; Gene mutations; Genes, BRCA1; Genes, BRCA2; Genetic aspects; Genetic Predisposition to Disease; Genetic research; Health aspects; Histology; Histopathology; Humans; Israel; Jews - genetics; Laboratories; Letter to JMG; Male; Medical genetics; Medical sciences; Middle Aged; Mutation; Nephrology. Urinary tract diseases; Pathology; pathology review; Physiological aspects; Prostate cancer; prostate specific antigen; Prostatic Neoplasms - ethnology; Prostatic Neoplasms - genetics; Prostatic Neoplasms - pathology; PSA; Tumors of the urinary system; Urinary tract. Prostate gland
• ISSN: 0022-2593; 1468-6244; 1468-6244
• DOI: 10.1136/jmg.40.10.787